134 related articles for article (PubMed ID: 19165078)
1. Cost-utility analysis of the cyberknife system for metastatic spinal tumors.
Papatheofanis FJ; Williams E; Chang SD
Neurosurgery; 2009 Feb; 64(2 Suppl):A73-83. PubMed ID: 19165078
[TBL] [Abstract][Full Text] [Related]
2. Treatment of spinal tumors using cyberknife fractionated stereotactic radiosurgery: pain and quality-of-life assessment after treatment in 200 patients.
Gagnon GJ; Nasr NM; Liao JJ; Molzahn I; Marsh D; McRae D; Henderson FC
Neurosurgery; 2009 Feb; 64(2):297-306; discussion 306-7. PubMed ID: 19057426
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases.
Lal LS; Byfield SD; Chang EL; Franzini L; Miller LA; Arbuckle R; Reasonda L; Feng C; Adamus A; Swint JM
Am J Clin Oncol; 2012 Feb; 35(1):45-50. PubMed ID: 21293245
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis.
Haley ML; Gerszten PC; Heron DE; Chang YF; Atteberry DS; Burton SA
J Neurosurg Spine; 2011 Apr; 14(4):537-42. PubMed ID: 21314284
[TBL] [Abstract][Full Text] [Related]
5. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
Konski A; Watkins-Bruner D; Feigenberg S; Hanlon A; Kulkarni S; Beck JR; Horwitz EM; Pollack A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):408-15. PubMed ID: 16887291
[TBL] [Abstract][Full Text] [Related]
6. Cyberknife radiosurgery for metastatic spine tumors.
Gerszten PC; Welch WC
Neurosurg Clin N Am; 2004 Oct; 15(4):491-501. PubMed ID: 15450884
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
[TBL] [Abstract][Full Text] [Related]
8. The costs and cost-effectiveness of an integrated sepsis treatment protocol.
Talmor D; Greenberg D; Howell MD; Lisbon A; Novack V; Shapiro N
Crit Care Med; 2008 Apr; 36(4):1168-74. PubMed ID: 18379243
[TBL] [Abstract][Full Text] [Related]
9. Economic impact of stereotactic radiosurgery for malignant intracranial brain tumors.
Lal LS; Franzini L; Panchal J; Chang E; Meyers CA; Swint JM
Expert Rev Pharmacoecon Outcomes Res; 2011 Apr; 11(2):195-204. PubMed ID: 21476821
[TBL] [Abstract][Full Text] [Related]
10. Cyberknife radiosurgery for breast cancer spine metastases: a matched-pair analysis.
Gagnon GJ; Henderson FC; Gehan EA; Sanford D; Collins BT; Moulds JC; Dritschilo A
Cancer; 2007 Oct; 110(8):1796-802. PubMed ID: 17786939
[TBL] [Abstract][Full Text] [Related]
11. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of early noninvasive ventilation for ALS patients.
Gruis KL; Chernew ME; Brown DL
BMC Health Serv Res; 2005 Aug; 5():58. PubMed ID: 16131401
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.
Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada.
Wagner M; Goetghebeur M; Merikle E; Pandya A; Chu P; Taylor DC
Can J Clin Pharmacol; 2009; 16(2):e331-45. PubMed ID: 19531812
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness and cost utility of an organized screening programme for glaucoma.
Vaahtoranta-Lehtonen H; Tuulonen A; Aronen P; Sintonen H; Suoranta L; Kovanen N; Linna M; Läärä E; Malmivaara A
Acta Ophthalmol Scand; 2007 Aug; 85(5):508-18. PubMed ID: 17655612
[TBL] [Abstract][Full Text] [Related]
16. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
Kwon JS; Lu KH
Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD.
Oba Y
Am J Manag Care; 2009 Apr; 15(4):226-32. PubMed ID: 19355795
[TBL] [Abstract][Full Text] [Related]
19. Costs associated with ventricular assist device use in children.
Mahle WT; Ianucci G; Vincent RN; Kanter KR
Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755
[TBL] [Abstract][Full Text] [Related]
20. Delayed radiation-induced myelopathy after spinal radiosurgery.
Gibbs IC; Patil C; Gerszten PC; Adler JR; Burton SA
Neurosurgery; 2009 Feb; 64(2 Suppl):A67-72. PubMed ID: 19165076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
